Denmark-headquartered Novo Nordisk (NVO) has entered into a collaboration and exclusive worldwide license agreement with ...

Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.

Septerna's partnership with Novo Nordisk validates its GPCR drug discovery ... The stock trades below net cash even after the Novo deal, offering investors a rare opportunity to buy the pipeline ...

The upfront and near-term payment, backed by milestones that could take the total value of the licensing deal to around ... scalability," he said. Novo Nordisk and Septerna will jointly carry ...

Novo Nordisk has planted another seed to fuel the blossoming of its obesity business, inking an $812 million deal with Deep ...

The deal could total up to $2.2 billion for Septerna, including upfront and milestone payments, tiered royalties, and an option for profit-sharing on one program, with Novo Nordisk funding all R&D ...

The deal is big for a Bay Area drug industry in need of big wins. Septerna shares surged 55% in early trading. Peninsula startup nets Nobel winner, $100M to change drug discovery How taming a ...